baber/WOPTO huggingface dataset:
Patent FI-842113-A0 (FI)
Inventor: GHISALBA ORESTE
IPC: C12R1/38
Filed: 1984-05-25
Abstract: 1. Claims for Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Facultatively methylotrophic, DMF-degrading microorganisms of the genus Pseudomonas selected from the group of the following strains : DMF 3/3 (NRRL-B-15358), DMF 3/4 (NRRL-B-15359), DMF 3/5 (NRRL-B-15360), DMF 3/6 (NRRL-B-15361), DMF 3/11 (NRRL-B-15362), DMF 3/12 (NRRL-B-15363), DMF 4/4 (NRRL-B-15364), DMF 5/3 (NRRL-B-15365), DMF 5/5 (NRRL-B-15366), DMF 5/7 (NRRL-B-15367), DMF 5/8 (NRRL-B-15368), DMF 5/9 (NRRL-B-15369) and DMF 5/10 (NRRL-B-15370), the mixed culture DMF/HW 1-5 (NRRL-B-15371), a mutant derived from these microorganisms, or mixed cultures thereof, for the purification of industrial waste waters, characterised in that, in aqueous solution, they are able to degrade dimethylformamide, formamide, methyl- or ethyl-formamide, acetamide, methanol, ethanol, saccharides, lower alkanoates, methyl-, ethyl-, dimethyl- or trimethylammonium halides, dimethyl phosphite, trimethyl phosphite, hydantoin, creatine, creatinine, barbituric acid, choline, betaine, sarcosine, dimethylglycine, glycine, glyoxylic acid, N-formylamino acids, N-acetylamino acids, acetonitrile or isobutyronitrile or mixtures of these compounds, with an increase in the biomass. 1. Claims for Contracting State : AT A process for the microbiological purification of aqueous solutions containing dimethylformamide, formamide, methyl- or ethyl-formamide, acetamide, methanol, ethanol, saccharides, lower alkanoates, methyl-, ethyl-, dimethyl- or trimethyl-ammonium halides, dimethyl phosphite, trimethyl phosphite, hydantoin, creatine, creatinine, barbituric acid, choline, betaine, sarcosine, dimethylglycine, glycine, glyoxylic acid, N-formylamino acids, N-acetylamino acids, acetonitrile or isobutyronitrile or mixtures of these compounds, characterised in that there is cultured in such an aqueous solution a microorganism of the genus Pseudomonas selected from the group of the following strains : DMF 3/3 (NRRL-B-15358), DMF 3/4 (NRRL-B-15359), DMF 3/5 (NRRL-B-15360), DMF 3/6 (NRRL-B-15361), DMF 3/11 (NRRL-B-15362), DMF 3/12 (NRRL-B-15363), DMF 4/4 (NRRL-B-15364), DMF 5/3 (NRRL-B-15365), DMF 5/5 (NRRL-B-15366), DMF 5/7 (NRRL-B-15367), DMF 5/8 (NRRL-B-15368), DMF 5/9 (NRRL-B-15369) and DMF 5/10 (NRRL-B-15370), or a mutant derived from these microorganisms, or mixed cultures thereof, in the presence of essential inorganic salts and optionally a nitrogen source, at from approximately 20 degrees C to approximately 40 degrees C and at a pH of from approximately 4 to approximately 7.5, under aerobic conditions, and, if desired, the resulting biomass is isolated.
Patent FI-854874-A0 (FI)
Inventor: COQUARD JEAN
IPC: C08G69/34
Filed: 1985-12-10
Abstract: Homogeneous, flexible block copolyetheramides having a melting/softening point of at least 170 DEG  C., a glass transition temperature, measured at ZHE, of at most -5 DEG  C., and a melt viscosity of at least 500 poises, said block copolyetheramides comprising the oxyacid, or alkali or alkaline earth metal, such oxyacid salt catalyzed polycondensate of admixture of (i) a lactam having from 4 to 12 carbon atoms with (ii) a solution of (iii) a salt of a fatty acid dimer and a polyoxyalkylenediamine, or mixture thereof, with a triamine, in (iv) a solvent medium which comprises (1) a mixture of water and an aliphatic alcohol having less than 5 carbon atoms, (2) a water/alcohol/lactam mixture wherein the alcohol and lactam are as in (1), (3) a melt of said lactam, or (4) a mixture of water and a water-soluble such lactam, the stoichiometry of said salt (iii) having been carefully pre-adjusted such that the pH thereof is essentially that as exists at the equivalence point thereof, and said oxyacid comprising at least one acid function having a pKa of no greater than 4.
Patent FI-862898-A0 (FI)
Inventor: ETIENNE ALAIN
IPC: A61K47/02
Filed: 1986-07-10
Abstract: There is described a solid pharmaceutical preparation for oral administration which produces high and long-lasting blood and tissue levels, containing 9-deoxo-11-deoxy-9,11-[imino[2-(2-methoxyethoxy)-ethylidene]oxy]-(9S)- erythromycin as active substance, in which the active substance must be intimately mixed with a basic excipient in a ratio of 1 mol of active substance to at least 2 gram-equivalents of basic excipient, and the preparations are coated with a gastric juice-resistant lacquer which is soluble in a pH range of between 5.5 and 6.8, and processes for preparing them. The solid pharmaceutical preparations include tablets, pellets or granules and a syrup can be produced from the latter.
Patent FI-871512-A0 (FI)
Inventor: MAEYRAE-MAEKINEN ANNIKA
IPC: G01N33/04
Filed: 1987-04-07
Abstract: The invention relates to a test set suitable for the determination of antibiotics in milk and comprising a Streptococcus thermophilus T101 concentrate and a water-based protective agent in a dilution ratio of 4 to 5 x 10<-><2>. The invention is also concerned with a novel Streptococcus thermophilus T101 strain to be used in the test set and with a process of determining antibiotics in milk by means of said test set.
Patent FI-896235-A0 (FI)
Inventor: HONORE TAGE
IPC: A61P25/28
Filed: 1989-12-22
Abstract: Heterocyclic dihydroxyquinoxaline compounds having the formula <CHEM>  wherein R<1> is hydroxy, alkoxy, aryloxy, aralkyloxy, cycloalkylalkoxy, cycloalkoxy, or acyloxy; and R<5>, R<6>, R<7> and R<8> independently are hydrogen, NO2, halogen, CN, SO2NR min R min , SO2R min , CF3, or OR min , wherein R min  is hydrogen or C1-4-alkyl. The invention also relates to a method of preparing the compounds, pharmaceutical compositions thereof, and their use. The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters, particularly the quisqualate receptors, and especially as neuroleptics.
Patent FI-910714-A0 (FI)
Inventor: BERUBE RICHARD R
IPC: D21H21/52
Filed: 1991-02-13
Abstract: A low-abrasion calcined kaolin opacifying pigment composed of particles in the size range of about 70 to 84% by weight finer than 2 microns and having a color defined by Hunter Trisitimulus values of "L" within the range of 92 to 94, "a" within the range of < +>1.0 to < +>2.2 and "b" within the range of < +>6.4 to < +>7.5. The pigment is produced by novel wet processing including high solids degritting of a high iron, high titania content Tertiary kaolin without conventional fractionation, bleaching and dewatering to isolate a fine particle size fraction, followed by spray drying, pulverization, calcination and repulverization.
Patent FI-923546-A0 (FI)
Inventor: EGGLER JAMES F
IPC: C07D405/12
Filed: 1992-08-06
Abstract: Compounds of the formula <CHEM>  wherein R is an optionally substituted heteroaryl group such as 2-chromanyl, 2-pyridyl or 5-fluoro-2-benzothiazoyl;     X is O, S or (CH2)m; R<1> is phenyl or pyridyl, optionally substituted by one or more (C1-C3)alkyl, (C1-C3)alkoxy, carboxy or [(C1-C3)alkoxy]carbonyl groups;     n is 0, 1 or 2;     m is 1 or 2; Y and Y<1> are taken together and are oxygen, or Y and Y<1> are taken separately, Y is hydrogen and Y<1> is hydroxy or an in vivo hydrolyzable acyloxy group;     Z is CH2 NR<2>, O or S; and     R<2> is hydrogen or (C1-C3)alkyl; are useful in the treatment of asthma, arthritis and related diseases mediated by leukotrienes.
Patent FI-925394-A0 (FI)
Inventor: PHILLIPS JOSEPH
IPC: D21C9/04
Filed: 1992-11-27
Abstract: Located within the annular screen (15) of the pressure diffuser (10) is a tubular baffle (40) hung from adjacent the top of the vessel (11). The baffle has two headers (17, 18) disposed on its inner surface, with openings (44, 45) in the tube providing communication between the exterior of the tube and the headers. A conduit (20, 21) extends from each header to an arm at the top of the vessel, to allow extracted liquid to be discharged. Another extraction conduit (19) is provided at the bottom of the vessel, in communication with the screen interior (16) and the tubular baffle interior. Treatment liquid, such as wash liquid, may be introduced at two, three, or more positions along the vessel with the liquid extracted from the first and second headers being introduceable at different positions along the vessel. A flexible, elastomeric material, sealing element (25, 26) with integral annular skirt (28) may extend from the bottom end of the tubular baffle and engage the screen to provide a seal minimizing mixing between stages (Figure 5). <IMAGE>
Patent FI-933744-A0 (FI)
Inventor: MAKKONEN MATTI
IPC: H04M3/44
Filed: 1993-08-26
Abstract: PCT No. PCT/FI93/00336 Sec. 371 Date May 17, 1995 Sec. 102(e) Date May 17, 1995 PCT Filed Aug. 26, 1993 PCT Pub. No. WO94/05126 PCT Pub. Date Mar. 3, 1994A wireless PBX system having at least one predetermined coverage area, and having a predefined group of mobile communication devices associated with each predetermined coverage area is provided. Each of the mobile communication devices belonging to a predefined group includes a first telephone number by which the mobile communication device may be reached via a wireless network, and a second, short extension number, identifying the mobile communication device as belonging to a particular group. Mobile communication devices within one of the at least one predefined groups may reach other mobile communication devices within their group or within another group by dialing the second extension number of the desired recipient mobile communication device, and may reach other communication devices not associated with any group by dialing an appropriate telephone number. In accordance with the present invention, a charging register records data about calls made by each mobile communication device and enables charging of calls at various levels depending on whether a call was placed between two mobile communication devices within a particular group, whether a call was placed between two mobile communication devices in two different groups, and whether a call was placed between a mobile communication device of a particular group to a communication device not belonging to any group.
Patent FI-934471-A0 (FI)
Inventor: KENNELLY TERESA
IPC: B01J23/96
Filed: 1993-10-11
Abstract: A novel praseodymium-palladium oxide compound has the formula Pr4PdO7. The compound has utility as a catalyst for oxidation of combustion mixtures comprising oxygen (e.g., air) and gaseous carbonaceous fuels such as methane and displays excellent regeneration characteristics after exposure to decomposition-causing temperatures. The compound may be used in a catalyst composition by being coated as a washcoat on a suitable carrier. Catalytic combustion processes are carried out by contacting such combustion mixture with the catalyst under combustion conditions, including catalytically supported thermal combustion. Regeneration of over-temperatured catalyst is also provided for.
Patent FI-935241-A0 (FI)
Inventor: QUIRK RICHARD
IPC: C03B5/237
Filed: 1993-11-25
Abstract: A method of operating a regenerative glass furnace for melting glass for the manufacture of shaped glass articles so as to minimise emission of NOx in waste gases leaving the furnace, the furnace having sealed regenerators which act as heat exchangers, the method comprising supplying fuel in excess of that required for stoichiometric combustion to ensure that glass of the required quality at the required production rate is obtained, and that the waste gases leaving the furnace through the regenerators contain combustible material, and reacting said combustible material with sufficient air to ensure that the waste gases exiting to atmosphere contain permissible levels of combustible material and contain permissible levels of NOx. Alternatively, the furnace may be operated at substantially stoichiometric conditions and fuel is supplied to waste gases as they leave the melting chamber. The invention also relates to a regenerator glass furnace for use in the method. The invention further provides a method of reducing the emissions of CO in waste gases leaving a cross-fired regenerative glass furnace for melting glass for the manufacture of shaped glass articles, the furnace having sealed regenerators which act as heat exchangers, the method comprising removing CO from the waste gases in the regenerator by combusting CO in around 8% excess air, based on the combustion air for the supplied fuel, at a temperature greater than 650 DEG C. <IMAGE>
Patent FI-942002-A0 (FI)
Inventor: COUPET JEAN MARIE
IPC: E06B3/46
Filed: 1994-04-29
Abstract: The covering section member (3) comprises a generally U-shaped internal housing delimited by two lateral branches and a transverse upright; the first lateral branch has a coupling or snap-fastening shoulder and is elastically deformable to a first level of deformation, having a thickness (g) smaller than the mean thickness of the section member, at least in the area where elastic deformation is needed; the internal housing comprises a first bearing zone (22a) corresponding to the coupling shoulder or located close to the snap-fastening shoulder, a second bearing zone located on the same side of the internal housing and a third bearing zone located on the second lateral branch and situated at an intermediate distance between the two first bearing zones. The section member (3) covers either a panel (14) or a section member (2) for fixing the panel, after insertion of one or other of these into the internal housing. The combination of the covering section member (3) and the fixing section member (2) constitutes a frame element for the panel. <IMAGE>
Patent FI-955084-A0 (FI)
Inventor: ANDRIEUX JEAN
IPC: C07C275/64
Filed: 1995-10-25
Abstract: O-Aryl methyl N-acyl or N-thioacyl hydroxylamine derivs. of formula ArCH2ON(R1)C(=X)R2 (I), their enantiomers and diastereoisomers are new. X = O or S; R1 = H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, or arylalkyl; R2 = R21 or R22; R21 = H or alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkylalkyl all of which may be substd.; R22 = alkylamino, cycloalkylamino, or cycloalkylalkylamino which may be substd. on the (cyclo)alkyl gps.; Ar = naphthyl, indolyl, benzofuranyl, or benzothiophenyl, all of which may be partially or fully hydrogenated. alkyl, alkoxy = 1-6C, alkenyl, alkynyl = 2-6C, cycloalkyl = 3-8C, and opt. substits. on these may be halo, alkyl or alkoxy. Opt. substits. on Ar gps. are one or more gps. R; R = halo, OH, Ra, -CH2Ra, -O-Ra, -CO-Ra or -O-CO-Ra; Ra = opt. substd. alkyl, alkenyl, alkynyl, opt. substd. cycloalkyl, opt. substd. cycloalkylalkyl, opt. substd. aryl or opt. substd. aralkyl; the substits. on aryl and aralkyl gps. may be halo, alkyl, alkoxy, OH and/or haloalkyl.
Patent FI-955988-A0 (FI)
Inventor: TAIJONLAHTI JORMA
IPC: B21D45/00
Filed: 1995-12-14
Abstract: PCT No. PCT/FI96/00625 Sec. 371 Date Oct. 27, 1997 Sec. 102(e) Date Oct. 27, 1997 PCT Filed Nov. 19, 1996 PCT Pub. No. WO97/21503 PCT Pub. Date Jun. 19, 1997The invention relates to a sheet metal work center, in which a locking arrangement (15) is placed between the stationary part (9) of the buffer structure (2) and the releaser (13), wherein at least some of the vertical movements of the upper tool (7) and the releaser (13) can be implemented by using the transfer device (12), the stationary part (9) of the buffer structure (2) and the releaser (13) being connected with the locking arrangement (15).
Patent FI-962294-A0 (FI)
Inventor: STEPHAN RONAN
IPC: H01G4/30
Filed: 1996-05-31
Abstract: Method for the manufacture of a stacked-type capacitor and/or resistance consisting of alternating dielectric layers and conducting layers. The dielectric layers are deposited by polymerization of the elements derived from the dissociation, by remote nitrogen plasma, of an organo-siliceous or organo-germanium gas. The conducting layers are formed simultaneously by the deposition of a conducting polymer derived from the dissociation, by remote nitrogen plasma, of hydrogen sulphide or sulphur dichloride. The dielectric and conducting layers are deposited on a dielectric substrate placed on the surface of a rotating drum, the rotation being such that the same portion of dielectric substrate is successively opposite at least one dielectric deposition device and at least one conducting polymer deposition device, each dielectric or conducting deposition being preceded by masking of the areas where no layer is to be deposited.
Patent FI-963925-A0 (FI)
Inventor: HIPPELAEINEN LASSI
IPC: G06F1/00
Filed: 1996-09-30
Abstract: A method of marking information to be produced in order to expose unauthorized copying. In the method, a user identifier is defined, a source file containing a substantial part of the information produced is created, and a different target file is created for each user on the basis of the source file and the user identifier. In the invention, several predefined modification rules are stored in a file in order to modify the information contained in the source file. Using a digital processor, a sequence of modification keys is generated on the basis of the user identifier, the locations of the source file to be modified are defined, and modifications are made in these locations, determining the nature and/or position of the modifications on the basis of the predefined modification rules and modification keys. From the content of the target file delivered to the user, it is possible to conclude a user-specific identifier and thereby the person responsible for the unauthorized copy.
Patent FI-973155-A0 (FI)
Inventor: MUELLER BEAT
IPC: C08J3/24
Filed: 1997-07-30
Abstract: PCT No. PCT/EP96/00253 Sec. 371 Date Sep. 12, 1997 Sec. 102(e) Date Sep. 12, 1997 PCT Filed Jan. 23, 1996 PCT Pub. No. WO96/24077 PCT Pub. Date Aug. 8, 1996The invention relates to a novel process for the production of mouldings, in particular contact lenses, in which a crosslinkable polymer comprising units containing crosslinkable groups, units containing a bound photoinitiator and, if desired, units containing further modifiers is crosslinked in solution, and to mouldings, in particular contact lenses, obtainable by this process. The present invention likewise relates to novel crosslinkable polymers which can be employed in the process, in particular derivatives of a polyvinyl alcohol having a molecular weight of at least about 2000 which comprises from about 0.5 to about 80%, based on the number of hydroxyl groups in the polyvinyl alcohol, of units of the formula I in which the variables are as defined in the description, and units of the formula IV, as defined in the description, which contain a bound photoinitiator.
Patent FI-982391-A0 (FI)
Inventor: KOKKOLA TOMMI
IPC: H04W4/16
Filed: 1998-11-04
Abstract: A telecommunications system comprising an arrangement for controlling a multicall over a transmission path between a telecommunications network and a subscriber terminal. A multicall may have three different bearer configurations: each call of the multicall has a dedicated bearer, or one bearer is shared by all calls of the multicall, or the multicall has both dedicated and shared bearers. When a shared bearer is used, a user can have several independent calls in parallel, which have to alternate in using the bearer, or in some situations, use it simultaneously. The network is arranged to set up any new call in an existing multicall, according to a criterion, either by (i) setting up said new call on a new bearer, or (ii) setting up said new call on an existing bearer so that said existing bearer is shared by at least two calls.
Patent FI-991493-A0 (FI)
Inventor: SOLALA ERKKI
IPC: H04L29/08
Filed: 1999-06-30
Abstract: The invention relates to a gateway server for receiving a message from a terminal and comprising a protocol stack ( 50 ) for processing the message according to a particular protocol stack. The server further comprises license control means ( 53 ) for controlling the access right of the message to enter the server before the message is allowed to pass to the protocol stack ( 50 ). The invention also relates to a method and a computer program product for controlling, at a server, access right of a message received from a terminal at the server.
Patent IL-65935-A0 (IL)
Title: Process for the lowering of the oxidation state of metal salts
IPC: C22B3/00
Filed: 1982-06-01
Abstract: The oxidation state of metal salts is lowered by contacting a solution of the salt with polyacetylene in the presence of sufficient moisture to leave the polyacetylene substantially undoped. The metal salt must have a reductive capacity of at least +0.5. This process can be used to reduce metal salts to zero active valency metal. The moisture is effectively added by treating an aqueous solution of the salt, optionally with organic cosolvent. The zero valency metal can subsequently be recovered from the polyacetylene, for example by burning the polyacetylene off.
Patent IL-66632-A0 (IL)
Title: 1-aryloxy-3-alkynylamino-propan-2-ols,their preparation and pharmaceutical compositions containing them
IPC: A61K31/135
Filed: 1982-08-24
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is cycloalkyl of 3 to 10 carbon atoms; phenyl; mono- or poly-substituted phenyl, where the substituents are halogen, lower alkyl, lower alkoxy, lower alkenyl, lower alkenyloxy, lower alkinyl, nitro, trifluoromethyl, hydroxyl, acyl, acyloxy, lower alkoxycarbonyl, hydroxy-lower alkyl, lower alkoxy-lower alkyl or the ring-forming groups (-CH=CH-)2 or -O-CH2-O- attached to vicinal carbon atoms of the phenyl ring; aryloxy-lower alkyl; (mono- or poly-substituted aryl)-oxy-lower alkyl, where the substituents are halogen, lower alkyl, lower alkoxy, lower alkenyl, lower alkinyl, acyl, acyloxy, nitro, trifluoromethyl or the ring-forming groups (-CH=CH-)2 or -O-CH2-O- attached to vicinal carbon atoms of the aryl ring; R2 is hydrogen, halogen, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or the ring-forming group (-CH=CH )2 or -(CH2)n-, where n is an integer from 3 to 5, attached to vicinal carbon atoms of the phenyl ring; R3 is hydrogen or alkyl of 1 to 3 carbon atoms; and R4 is alkyl of 1 to 3 carbon atoms or, together with R3, a ring-forming group -(CH2)p-, where p is an integer from 4 to 6; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful for the treatment of tachycardia, hypertension and coronary diseases.